T2 Biosystems, Inc. 8-K Report: Key Updates from January 16, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Company Identification:

• Name: T2 Biosystems, Inc.
• CIK Number: 0001492674
• State of Incorporation: Delaware (DE)
• IRS Employer Identification Number (EIN): 20-4827488
• Address: 101 Hartwell Avenue, Lexington, MA 02421
• Phone Number: (781) 761-4646

2. Filing Information:

• Filing Type: 8-K (Current Report)
• Filing Date: January 16, 2025
• SEC File Number: 001-36571

3. Stock Information:

• Common Stock Par Value: $0.001 per share
• Stock Symbol: TTOO
• Stock Exchange: NASDAQ

4. Reporting Context:

• Period Covered: The report covers a single day, January 16, 2025.
• Duration ID: duration_2025-01-16_to_2025-01-16

Insights:

• The filing is an 8-K, typically used to report significant events or corporate changes that may affect the company or its securities.
• The date of the report indicates it is likely to contain timely information regarding recent developments in the company as of January 16, 2025.
• The company's stock is publicly traded on NASDAQ, which provides a platform for investor evaluation and access to market performance data.

This information is critical for investors and stakeholders monitoring T2 Biosystems, Inc. for compliance, operational updates, or market activity.